title: Intestinal transport of weak electrolytes. Evidence in favor of a three-compartment system.
abstract: A study has been made of the transmural fluxes of benzoic, phenylacetic, and pentanoic acids, benzylamine, hexylamine, and D-amphetamine across rat jejunum incubated in vitro. The M to S fluxes of the weak acids were greater than their corresponding S to M fluxes, and the S to M fluxes of the weak bases were larger than their M to S fluxes. These patterns of asymmetric movements were observed when the transmural electrical potential difference was clamped at 0 mV, and when the pH values of the mucosal and serosal fluids were identical. The effects of a weak acid on the fluxes of other weak electrolytes were qualitatively similar when the effector weak acid was added to the mucosal fluid, and when it was added to the serosal fluid. But the effects of a weak base on the fluxes of other weak electrolytes were dependent upon its location, and the interactions observed when the effector weak base was added to the mucosal fluid were qualitatively different than those seen when it was added to the serosal fluid. The interactions between weak electrolytes could readily be explained in terms of the function of a system of three compartments in series, in which the pH of the intermediate compartment is greater than that of the bulk phases. But these observations could not be explained in terms of an analogous system involving an intermediate compartment of low pH, or in terms of a carrier mediated system. The transport function of the three-compartment system can be described in the form of an equation, and it is found that a pH difference of less than 0.5 unit may explain our observations on weak electrolyte transport.
mesh_terms: D000588:Amines / Q000378:metabolism*; D000661:Amphetamine / Q000378:metabolism*; D000818:Animals; D001565:Benzoates / Q000378:metabolism*; D001593:Benzyl Compounds / Q000378:metabolism*; D001692:Biological Transport; D001693:Biological Transport, Active; D004594:Electrophysiology; D005690:Galactose / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D012704:Serous Membrane / Q000378:metabolism; D013997:Time Factors; D014508:Urea / Q000378:metabolism; D014631:Valerates / Q000378:metabolism*
chemical_list: D000588:Amines; D001565:Benzoates; D001593:Benzyl Compounds; D010648:Phenylacetates; D014631:Valerates; D014508:Urea; C007940:hexylamine; D000661:Amphetamine; D005947:Glucose; D005690:Galactose